Global Plant-based Biologics Market
Global Plant-based Biologics Market

Plant-based Biologics Comprehensive Study by Source (Carrot, Tobacco, Duckweed, Rice, Moss, Alfalfa, Others), Plant Parts (Leaf-based, Seeds-based, Fruits-based, Tubers-based, Other) Players and Region - Global Market Outlook to 2025

Plant-based Biologics Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Aug 2020 Edition 241 Pages 214 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Plant-based Biologics Market Overview:
Plant-based biologics can be defined as a Schedule D (biologic) drug produced using plant molecular farming. It is the outcome of an advanced application of biotechnology on plants that enables them to produce therapeutic protein. Plant-based biologics is considered as a perfect substitute for traditional techniques that uses microbial fermentation or animal cell culture. This technology is well-equipped in providing patients greater and immediate access to treatments and is foreseen to expand its uses in the upcoming years. Some of the key players profiled in the study are Fraunhofer IME (Germany), PlantForm (Canada), Mapp Biopharmaceautical (United States), Kentucky BioProcessing, Inc. (United States), Icon Genetics GmbH (Germany), Medicago, Inc. (Canada), iBio Inc. (United States), Greenovation Biotech GmbH (Germany) and Ventria Bioscience Inc. (United States).

On the basis of geography, the market of Plant-based Biologics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Source , the sub-segment i.e. Carrot will boost the Plant-based Biologics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Plant Parts, the sub-segment i.e. Leaf-based will boost the Plant-based Biologics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increase in the Number of Chronic Diseases and Consequent Demand for Biologics
  • Advancements in Plant Biotechnology Area

Market Trend
  • Technological innovations related to the Production of Plant-Derived Biologics Drugs

Restraints
  • High Cost for R& D

Opportunities
  • Low Cost of Manufacturing for the Production of Plant-based Biologics
  • Used as Biocontrol Agents of Foodborne Pathogens

Challenges
  • Strict Government Regulation


In April 2020 iBio, Inc., a biologics contract manufacturing organization and biotechnology company, provided an update on its COVID-19 vaccine manufacturing capacity and announced that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (“NIIMBL”), one of 14 institutes in the Manufacturing USA Network.


Target Audience:
Research and Development Institutes, Potential Investors, Regulatory Bodies, National Laboratories, Industry Associations and Others

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Plant-based Biologics market on the basis of product [] , application [], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Plant-based Biologics market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Plant-based Biologics industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Plant-based Biologics market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Source
  • Carrot
  • Tobacco
  • Duckweed
  • Rice
  • Moss
  • Alfalfa
  • Others

By Plant Parts
  • Leaf-based
  • Seeds-based
  • Fruits-based
  • Tubers-based
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Number of Chronic Diseases and Consequent Demand for Biologics
      • 3.2.2. Advancements in Plant Biotechnology Area
    • 3.3. Market Challenges
      • 3.3.1. Strict Government Regulation
    • 3.4. Market Trends
      • 3.4.1. Technological innovations related to the Production of Plant-Derived Biologics Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Plant-based Biologics, by Source , Plant Parts and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Plant-based Biologics (Value)
      • 5.2.1. Global Plant-based Biologics by: Plant Parts (Value)
        • 5.2.1.1. Leaf-based
        • 5.2.1.2. Seeds-based
        • 5.2.1.3. Fruits-based
        • 5.2.1.4. Tubers-based
        • 5.2.1.5. Other
      • 5.2.2. Global Plant-based Biologics Region
        • 5.2.2.1. South America
          • 5.2.2.1.1. Brazil
          • 5.2.2.1.2. Argentina
          • 5.2.2.1.3. Rest of South America
        • 5.2.2.2. Asia Pacific
          • 5.2.2.2.1. China
          • 5.2.2.2.2. Japan
          • 5.2.2.2.3. India
          • 5.2.2.2.4. South Korea
          • 5.2.2.2.5. Taiwan
          • 5.2.2.2.6. Australia
          • 5.2.2.2.7. Rest of Asia-Pacific
        • 5.2.2.3. Europe
          • 5.2.2.3.1. Germany
          • 5.2.2.3.2. France
          • 5.2.2.3.3. Italy
          • 5.2.2.3.4. United Kingdom
          • 5.2.2.3.5. Netherlands
          • 5.2.2.3.6. Rest of Europe
        • 5.2.2.4. MEA
          • 5.2.2.4.1. Middle East
          • 5.2.2.4.2. Africa
        • 5.2.2.5. North America
          • 5.2.2.5.1. United States
          • 5.2.2.5.2. Canada
          • 5.2.2.5.3. Mexico
  • 6. Plant-based Biologics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Fraunhofer IME (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. PlantForm (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Mapp Biopharmaceautical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Kentucky BioProcessing, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Icon Genetics GmbH (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medicago, Inc. (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. IBio Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Greenovation Biotech GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Ventria Bioscience Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Plant-based Biologics Sale, by Source , Plant Parts and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Plant-based Biologics (Value)
      • 7.2.1. Global Plant-based Biologics by: Plant Parts (Value)
        • 7.2.1.1. Leaf-based
        • 7.2.1.2. Seeds-based
        • 7.2.1.3. Fruits-based
        • 7.2.1.4. Tubers-based
        • 7.2.1.5. Other
      • 7.2.2. Global Plant-based Biologics Region
        • 7.2.2.1. South America
          • 7.2.2.1.1. Brazil
          • 7.2.2.1.2. Argentina
          • 7.2.2.1.3. Rest of South America
        • 7.2.2.2. Asia Pacific
          • 7.2.2.2.1. China
          • 7.2.2.2.2. Japan
          • 7.2.2.2.3. India
          • 7.2.2.2.4. South Korea
          • 7.2.2.2.5. Taiwan
          • 7.2.2.2.6. Australia
          • 7.2.2.2.7. Rest of Asia-Pacific
        • 7.2.2.3. Europe
          • 7.2.2.3.1. Germany
          • 7.2.2.3.2. France
          • 7.2.2.3.3. Italy
          • 7.2.2.3.4. United Kingdom
          • 7.2.2.3.5. Netherlands
          • 7.2.2.3.6. Rest of Europe
        • 7.2.2.4. MEA
          • 7.2.2.4.1. Middle East
          • 7.2.2.4.2. Africa
        • 7.2.2.5. North America
          • 7.2.2.5.1. United States
          • 7.2.2.5.2. Canada
          • 7.2.2.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Plant-based Biologics: by Plant Parts(USD Million)
  • Table 2. Plant-based Biologics Leaf-based , by Region USD Million (2014-2019)
  • Table 3. Plant-based Biologics Seeds-based , by Region USD Million (2014-2019)
  • Table 4. Plant-based Biologics Fruits-based , by Region USD Million (2014-2019)
  • Table 5. Plant-based Biologics Tubers-based , by Region USD Million (2014-2019)
  • Table 6. Plant-based Biologics Other , by Region USD Million (2014-2019)
  • Table 7. South America Plant-based Biologics, by Country USD Million (2014-2019)
  • Table 8. South America Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 9. South America Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 10. Brazil Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 11. Brazil Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 12. Argentina Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 13. Argentina Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 14. Rest of South America Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 15. Rest of South America Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 16. Asia Pacific Plant-based Biologics, by Country USD Million (2014-2019)
  • Table 17. Asia Pacific Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 18. Asia Pacific Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 19. China Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 20. China Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 21. Japan Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 22. Japan Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 23. India Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 24. India Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 25. South Korea Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 26. South Korea Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 27. Taiwan Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 28. Taiwan Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 29. Australia Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 30. Australia Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 31. Rest of Asia-Pacific Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 32. Rest of Asia-Pacific Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 33. Europe Plant-based Biologics, by Country USD Million (2014-2019)
  • Table 34. Europe Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 35. Europe Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 36. Germany Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 37. Germany Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 38. France Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 39. France Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 40. Italy Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 41. Italy Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 42. United Kingdom Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 43. United Kingdom Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 44. Netherlands Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 45. Netherlands Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 46. Rest of Europe Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 47. Rest of Europe Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 48. MEA Plant-based Biologics, by Country USD Million (2014-2019)
  • Table 49. MEA Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 50. MEA Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 51. Middle East Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 52. Middle East Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 53. Africa Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 54. Africa Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 55. North America Plant-based Biologics, by Country USD Million (2014-2019)
  • Table 56. North America Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 57. North America Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 58. United States Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 59. United States Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 60. Canada Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 61. Canada Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 62. Mexico Plant-based Biologics, by Source USD Million (2014-2019)
  • Table 63. Mexico Plant-based Biologics, by Plant Parts USD Million (2014-2019)
  • Table 64. Company Basic Information, Sales Area and Its Competitors
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Plant-based Biologics: by Plant Parts(USD Million)
  • Table 74. Plant-based Biologics Leaf-based , by Region USD Million (2020-2025)
  • Table 75. Plant-based Biologics Seeds-based , by Region USD Million (2020-2025)
  • Table 76. Plant-based Biologics Fruits-based , by Region USD Million (2020-2025)
  • Table 77. Plant-based Biologics Tubers-based , by Region USD Million (2020-2025)
  • Table 78. Plant-based Biologics Other , by Region USD Million (2020-2025)
  • Table 79. South America Plant-based Biologics, by Country USD Million (2020-2025)
  • Table 80. South America Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 81. South America Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 82. Brazil Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 83. Brazil Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 84. Argentina Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 85. Argentina Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 86. Rest of South America Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 87. Rest of South America Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 88. Asia Pacific Plant-based Biologics, by Country USD Million (2020-2025)
  • Table 89. Asia Pacific Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 90. Asia Pacific Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 91. China Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 92. China Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 93. Japan Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 94. Japan Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 95. India Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 96. India Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 97. South Korea Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 98. South Korea Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 99. Taiwan Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 100. Taiwan Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 101. Australia Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 102. Australia Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 103. Rest of Asia-Pacific Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 104. Rest of Asia-Pacific Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 105. Europe Plant-based Biologics, by Country USD Million (2020-2025)
  • Table 106. Europe Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 107. Europe Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 108. Germany Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 109. Germany Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 110. France Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 111. France Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 112. Italy Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 113. Italy Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 114. United Kingdom Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 115. United Kingdom Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 116. Netherlands Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 117. Netherlands Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 118. Rest of Europe Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 119. Rest of Europe Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 120. MEA Plant-based Biologics, by Country USD Million (2020-2025)
  • Table 121. MEA Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 122. MEA Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 123. Middle East Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 124. Middle East Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 125. Africa Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 126. Africa Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 127. North America Plant-based Biologics, by Country USD Million (2020-2025)
  • Table 128. North America Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 129. North America Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 130. United States Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 131. United States Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 132. Canada Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 133. Canada Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 134. Mexico Plant-based Biologics, by Source USD Million (2020-2025)
  • Table 135. Mexico Plant-based Biologics, by Plant Parts USD Million (2020-2025)
  • Table 136. Research Programs/Design for This Report
  • Table 137. Key Data Information from Secondary Sources
  • Table 138. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Plant-based Biologics: by Plant Parts USD Million (2014-2019)
  • Figure 5. South America Plant-based Biologics Share (%), by Country
  • Figure 6. Asia Pacific Plant-based Biologics Share (%), by Country
  • Figure 7. Europe Plant-based Biologics Share (%), by Country
  • Figure 8. MEA Plant-based Biologics Share (%), by Country
  • Figure 9. North America Plant-based Biologics Share (%), by Country
  • Figure 10. Global Plant-based Biologics share by Players 2019 (%)
  • Figure 11. Global Plant-based Biologics share by Players (Top 3) 2019(%)
  • Figure 12. Global Plant-based Biologics share by Players (Top 5) 2019(%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Fraunhofer IME (Germany) Revenue, Net Income and Gross profit
  • Figure 15. Fraunhofer IME (Germany) Revenue: by Geography 2019
  • Figure 16. PlantForm (Canada) Revenue, Net Income and Gross profit
  • Figure 17. PlantForm (Canada) Revenue: by Geography 2019
  • Figure 18. Mapp Biopharmaceautical (United States) Revenue, Net Income and Gross profit
  • Figure 19. Mapp Biopharmaceautical (United States) Revenue: by Geography 2019
  • Figure 20. Kentucky BioProcessing, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Kentucky BioProcessing, Inc. (United States) Revenue: by Geography 2019
  • Figure 22. Icon Genetics GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Icon Genetics GmbH (Germany) Revenue: by Geography 2019
  • Figure 24. Medicago, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 25. Medicago, Inc. (Canada) Revenue: by Geography 2019
  • Figure 26. IBio Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. IBio Inc. (United States) Revenue: by Geography 2019
  • Figure 28. Greenovation Biotech GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Greenovation Biotech GmbH (Germany) Revenue: by Geography 2019
  • Figure 30. Ventria Bioscience Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Ventria Bioscience Inc. (United States) Revenue: by Geography 2019
  • Figure 32. Global Plant-based Biologics: by Plant Parts USD Million (2020-2025)
  • Figure 33. South America Plant-based Biologics Share (%), by Country
  • Figure 34. Asia Pacific Plant-based Biologics Share (%), by Country
  • Figure 35. Europe Plant-based Biologics Share (%), by Country
  • Figure 36. MEA Plant-based Biologics Share (%), by Country
  • Figure 37. North America Plant-based Biologics Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Fraunhofer IME (Germany)
  • PlantForm (Canada)
  • Mapp Biopharmaceautical (United States)
  • Kentucky BioProcessing, Inc. (United States)
  • Icon Genetics GmbH (Germany)
  • Medicago, Inc. (Canada)
  • iBio Inc. (United States)
  • Greenovation Biotech GmbH (Germany)
  • Ventria Bioscience Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation